UK agrees deals for 114 million more Moderna and Pfizer Covid-19 doses

So far, nearly 51 million people in Britain have received their first Covid-19 vaccine dose - almost 89 per cent of the population aged over 12. PHOTO: AFP

Updated

Published

Dec 02, 2021, 06:53 AM

LONDON (REUTERS) - Britain said on Wednesday (Dec 1) it had agreed deals to buy 114 million more Pfizer-BioNTech and Moderna Covid-19 vaccine shots, saying it had sped up signing the new contracts in the light of the emergence of the new Omicron variant.

The deal involves an additional 60 million Moderna shots and 54 million Pfizer-BioNTech doses for next year and 2023, and will also include access to any modified vaccinations if these are needed to combat the Omicron strain or any other variant, the British Health Ministry said.

"These new deals will future-proof the great British vaccination effort - which has so far delivered more than 115 million first, second and booster jabs across the UK - and will ensure we can protect even more people in the years ahead," Health Minister Sajid Javid said.

So far, nearly 51 million people in Britain have received their first Covid-19 vaccine dose - almost 89 per cent of the population aged over 12; more than 46 million have had two doses; and some 18.6 million have received a booster shot.

On Tuesday, Prime Minister Boris Johnson announced a new target this week to offer all adults a vaccine booster by the end of January, which means speeding up the roll-out by an extra million doses a week.

So far, 32 cases of the heavily mutated Omicron variant, which it is feared could be more transmissible, have been identified in Britain, sparking the government into ramping up the vaccine programme.

Britain has made it mandatory for people to wear masks on public transport and shops, but Mr Johnson and his ministers hope the booster programme will mean that there will be no need for further restrictions or measures to curb social gatherings.

The contracts for the additional vaccines come on top of an order for 35 million Pfizer-BioNTech shots made in August for the second half of next year, and for 60 million Novavax and 7.5 million GlaxoSmithKline/Sanofi doses, which are due in 2022 but are yet to be approved by the British regulator.

Wealthy countries have been accused of not doing enough to distribute stockpiles of vaccines to poorer nations, and the British government said it remained committed to donating 100 million doses by the middle of 2022, saying 30 million would be donated by the end of this year.

Mr Johnson will also on Thursday host a round-table discussion of leaders from major pharmaceutical firms, including AstraZeneca, GSK and Pfizer, to discuss preparations to deal with any future pandemics.